The overall objective of the initiative is to educate this target audience involved in the care of patients with AF on the pharmacologic and interventional options to be considered and how they can be effectively incorporated into the management of patients. This educational initiative will review the challenges associated with determining AF status and co-morbidities that may affect AF management strategy, discuss clinical practice guidelines, the recently published CABANA trial, and help develop strategies to address care in various AF patient cohorts. The program is targeted to electrophysiologists, cardiologists, and other healthcare professions who diagnosis and treat patients with atrial fibrillation.
Enroll in this meeting
Enrollment Fee: FreeFree
6:00 PM Registration & Buffet Dinner
6:30 PM Program Overview
6:40 PM Explaining the CABANA Trial
6:55 PM Lessons Learned After CABANA
7:05 PM Q & A
7:15 PM Case Presentation #1
7:25 PM Case Presentation #2
7:35 PM Case Presentation #3
7:45 PM Post-Test Questions
8:00 PM Adjourn
This activity is designed to meet the educational needs of electrophysiologists, cardiologists, and other healthcare professions who diagnosis and treat patients with atrial fibrillation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and the Heart Rhythm Society (HRS). GLC is accredited by the ACCME to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an independent educational grant from Sanofi US.